DAA1376 |
DEAH (Asp-Glu-Ala-His) box polypeptide 40 |
Molecular |
hematological system |
Mouse |
Dhx40 |
12.0% Increase Gene Expression Level |
|
DAA1860 |
death associated protein 3 |
Molecular |
skeletal muscle |
Mouse |
Dap3 |
3.0% Decrease Gene Expression Level |
|
DAA1000 |
Decline in epidermis keratinocyte turnover |
Physiological |
epidermis |
Human |
— |
— |
|
DAA924 |
Decline in ovarian estrogen production |
Physiological |
ovary |
Human |
— |
— |
|
DAA806 |
Decline in respiratory muscle fibers |
Physiological |
respiratory system, muscle |
Human |
— |
— |
|
DAA806 |
Decline in respiratory muscle fibers |
Physiological |
respiratory system, muscle |
Human |
— |
— |
|
DAA1229 |
Declining T-lymphocyte production in the thymus |
Physiological |
thymus |
Human |
— |
— |
|
DAA2050 |
Decreased ability to maintain body temperature when exposed to cold |
Physiological |
whole body |
Human |
— |
— |
|
DAA1002 |
Decreased ability to modulate heat loss |
Physiological |
integument system |
Human |
— |
— |
|
DAA1006 |
Decreased amounts of collagen IV and VII, and abnormal elastin in dermis |
Physiological |
dermis |
Human |
— |
— |
|
DAA1004 |
Decreased/disorganized fibril network of dermis |
Physiological |
dermis |
Human |
— |
— |
|
DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
DAA1231 |
decreased NF-KappaB induction in T cells |
Molecular |
T cell |
Human |
— |
— |
|
DAA1232 |
decreased proteasomal activity in T cells |
Molecular |
T cell |
Human |
— |
— |
|
DAA796 |
Decrease in alveoli elasticity and recoil forces |
Physiological |
alveolus |
Human |
— |
— |
|
DAA829 |
Decrease in amplitude of peristaltic pressure wave in upper esophogeal sphincter |
Physiological |
oesophagus |
Human |
— |
— |
|
DAA1995 |
Decrease in collagen in the venous intima |
Physiological |
venous intima |
Human |
— |
42.0% Decrease Protein level |
|
DAA992 |
Decrease in dermal papillae density |
Physiological |
epidermis, dermis |
Human |
— |
— |
|
DAA992 |
Decrease in dermal papillae density |
Physiological |
epidermis, dermis |
Human |
— |
— |
|